Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
   
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations

More>>

Radu, A., Pichon, Ch., Antoine, M., Allorry, Y., Couvelard, A., Fromont, G., Hai, M.T.V. and Ghinea, N. (2010) Expression of Follicle-Stimulating Hormone Receptor in Tumor Blood Vessels. The New England Journal of Medicine, 363, 1621-1630.
http://dx.doi.org/10.1056/NEJMoa1001283

has been cited by the following article:

  • TITLE: Molecular Marker of Tumours

    AUTHORS: Marian Surma

    KEYWORDS: Cancer, Molecular Marker, Protein Markers

    JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.10, September 22, 2016

    ABSTRACT: Molecular structure of the marker of tumour is determined by magneto-optical analysis of blood serum. The marker is the laevorotatory enantiomer of alanine. The cancer status of a subject is described by the number of molecules of the laevorotatory alanine enantiomer (-)ρ and the effectiveness of therapy is measured by the number of molecules of the dextrorotatory alanine enantiomer (+)ρ. The values of (-)ρ and (+)ρ are determined separately for the patient before and after therapy.